Clivus chordomas: a systematic review and meta-analysis of contemporary surgical management

Moujahed Labidi1, Kentaro Watanabe, Schahrazad Bouazza

  • 1Department of Neurosurgery, Hôpital Lariboisière, Paris, France - Sebastien.froelich@aphp.fr.

Abstract

Insights

This study analyzed clivus chordoma surgeries, finding that the anterior midline approach (AMA) may offer higher rates of gross total resection (GTR) and potentially better outcomes. However, long-term survival data for AMA in chordoma treatment is still limited.

Area of Science:

  • Neurosurgery
  • Oncology
  • Otolaryngology

Background:

  • Chordomas are rare bone tumors originating from notochordal remnants.
  • Endoscopic surgery advances enable the use of the median endonasal corridor for chordoma cases.
  • Limited critical data exists comparing the anterior midline approach (AMA) to lateral/posterolateral transcranial corridors for chordomas.

Purpose of the Study:

  • To systematically review and analyze surgical approaches for clivus chordomas.
  • To compare the efficacy and outcomes of the anterior midline approach (AMA) versus other transcranial corridors.
  • To assess gross total resection (GTR) rates, complications, and survival outcomes in clivus chordoma treatment.

Main Methods:

  • Systematic literature search of EMBASE and PubMed (Jan 2006-Mar 2016).
  • Inclusion of surgical series specifically on clivus chordomas.
  • Meta-analysis of data including GTR rates, complications, recurrence, progression-free survival (PFS), and overall survival (OS).

Main Results:

  • Twenty-seven articles (1050 patients) were reviewed; weighted mean GTR rate was 39.9%.
  • Studies exclusively using AMA showed higher GTR rates (60.7%) compared to mixed series (42.0%).
  • AMA group had lower cranial nerve deficits and CNS infections but higher CSF leak incidence. Weighted 5-year PFS was 49.9%, 5-year OS was 73.9%. Recurrence was significantly lower with GTR (OR 0.289).

Conclusions:

  • Anterior midline approaches (AMA) may achieve higher GTR rates for clivus chordomas.
  • AMA might be associated with reduced neurological morbidity compared to traditional transcranial routes.
  • The long-term impact of AMA on chordoma survival and disease control requires further investigation.

Related Concept Videos